31
Participants
Start Date
June 1, 2017
Primary Completion Date
February 23, 2022
Study Completion Date
February 23, 2022
Statin
"Standard of care treatment (one of four):~* Simvastatin (to 40mg without amlodipine)~* Simvastatin (to 20 mg if currently on amlodipine)~* Atorvastatin (to 80mg)~* Rosuvastatin (to 20mg)"
Atorvastatin
"A lipid-lowering agent and for prevention of events associated with cardiovascular disease.~10 mg or 80 mg capsules"
Placebo
A placebo pill will be used for patients that are to maintain their current dose of statins prior to their CEA.
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
Valley Hospital, Ridgewood
Albany Medical College/The Vascular Group at Albany, Albany
State University of New York at Buffalo, Buffalo
New York University School of Medicine, New York
Cornell University Medical College (Weill), New York
Columbia University
OTHER